In HCC, pharmacological inhibition or knockout of USP8 reduces the stability of OGT, thereby suppressing HCC progression and inducing ferroptosis, indicating that targeting USP8 is a potential therapeutic strategy for HCC [68]. This evidence concerns the gene USP8 and hepatocellular carcinoma.